ArticleFrontiers in oncology2025

Predicting resectability after neoadjuvant chemotherapy for patients with borderline resectable pancreatic cancer: a single center, retrospective trial.

Florian Schepp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.